{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bioavailability", "boswellic acids", "combinatorial approaches", "curcumin", "medicinal plant", "metabolomics", "quercetin", "resveratrol", "tissue distribution", "tissue-plasma-ratio"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34066427", "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "06"}], "Language": ["eng"], "ELocationID": ["437", "10.3390/ph14050437"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "14", "Issue": "5", "PubDate": {"Year": "2021", "Month": "May", "Day": "06"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Considerations to Be Taken When Carrying Out Medicinal Plant Research-What We Learn from an Insight into the IC<sub>50</sub> Values, Bioavailability and Clinical Efficacy of Exemplary Anti-Inflammatory Herbal Components.", "Abstract": {"AbstractText": ["Medicinal plants represent a big reservoir for discovering new drugs against all kinds of diseases including inflammation. In spite the large number of promising anti-inflammatory plant extracts and isolated components, research on medicinal plants proves to be very difficult. Based on that background this review aims to provide a summarized insight into the hitherto known pharmacologically active concentrations, bioavailability, and clinical efficacy of boswellic acids, curcumin, quercetin and resveratrol. These examples have in common that the achieved plasma concentrations were found to be often far below the determined IC<sub>50</sub> values in vitro. On the other hand demonstrated therapeutic effects suggest a necessity of rethinking our pharmacokinetic understanding. In this light this review discusses the value of plasma levels as pharmacokinetic surrogates in comparison to the more informative value of tissue concentrations. Furthermore the need for new methodological approaches is addressed like the application of combinatorial approaches for identifying and pharmacokinetic investigations of active multi-components. Also the physiological relevance of exemplary in vitro assays and absorption studies in cell-line based models is discussed. All these topics should be ideally considered to avoid inaccurate predictions for the efficacy of herbal components in vivo and to unlock the \"black box\" of herbal mixtures."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Central Laboratory of German Pharmacists, Carl-Mannich-Str. 20, 65760 Eschborn, Germany."}, {"Identifier": [], "Affiliation": "Institute of Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Max-von-Laue-Stra\u00dfe 9, 60438 Frankfurt am Main, Germany."}], "LastName": "Abdel-Tawab", "ForeName": "Mona", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The author declares no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Germolec D.R., Shipkowski K.A., Frawley R.P., Evans E. Markers of Inflammation. Methods Mol. Biol. 2018;1803:57\u201379. doi: 10.1007/978-1-4939-8549-4_5.", "ArticleIdList": ["10.1007/978-1-4939-8549-4_5", "29882133"]}, {"Citation": "GBD 2017 Causes of Death Collaborators Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736\u20131788. doi: 10.1016/S0140-6736(18)32203-7.", "ArticleIdList": ["10.1016/S0140-6736(18)32203-7", "PMC6227606", "30496103"]}, {"Citation": "Patil K.R., Mahajan U.B., Unger B.S., Goyal S.N., Belemkar S., Surana S.J., Ojha S., Patil C.R. Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals. Int. J. Mol. Sci. 2019;20:4367. doi: 10.3390/ijms20184367.", "ArticleIdList": ["10.3390/ijms20184367", "PMC6770891", "31491986"]}, {"Citation": "Fuerst R., Zuendorf I. Plant derived anti-inflammatory compounds: Hopes and disappointments regarding the translation of preclinical knowledge into clinical progress. Mediators Inflamm. 2014;2014:146832. doi: 10.1155/2014/146832.", "ArticleIdList": ["10.1155/2014/146832", "PMC4060065", "24987194"]}, {"Citation": "Zhang J., Zhou F., Lu M., Ji W., Niu F., Zha W., Wu X., Hao H., Wang G. Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy. Curr. Drug Metab. 2012;13:558\u2013576. doi: 10.2174/1389200211209050558.", "ArticleIdList": ["10.2174/1389200211209050558", "22475335"]}, {"Citation": "Efferth T., Oesch F. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities. Semin. Cancer Biol. 2020 doi: 10.1016/j.semcancer.2020.01.015.", "ArticleIdList": ["10.1016/j.semcancer.2020.01.015", "32027979"]}, {"Citation": "Herrmann A., K\u00f6nig S., Lechtenberg M., Sehlbach M., Vakhrushev S.Y., Peter-Katalinic J., Hensel A. Proteoglycans from Boswellia serrata Roxb. and B. carterii Birdw. and identfication of a proteolytic plant basic secretory protein. Glycobiology. 2019;22:1424\u20131439. doi: 10.1093/glycob/cws107.", "ArticleIdList": ["10.1093/glycob/cws107", "22773449"]}, {"Citation": "Ammon H.P.T. Boswellic Acids and Their Role in Chronic Inflammatory Diseases. Adv. Exp. Med. Biol. 2016;928:291\u2013327. doi: 10.1007/978-3-319-41334-1_13.", "ArticleIdList": ["10.1007/978-3-319-41334-1_13", "27671822"]}, {"Citation": "Roy N.K., Parama D., Banik K., Bordoloi D., Devi A.K., Thakur K.K., Padmavathi G., Shakibaei M., Fan L., Sethi G., et al. An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases. Int. J. Mol. Sci. 2019;20:4101. doi: 10.3390/ijms20174101.", "ArticleIdList": ["10.3390/ijms20174101", "PMC6747466", "31443458"]}, {"Citation": "Koeberle A., Henkel A., Verhoff M., Tausch L., K\u00f6nig S., Fischer D., Kather N., Seitz S., Paul M., Jauch J., et al. Triterpene Acids from Frankincense and Semi-Synthetic Derivatives That Inhibit 5-Lipoxygenase and Cathepsin G. Molecules. 2018;23:506. doi: 10.3390/molecules23020506.", "ArticleIdList": ["10.3390/molecules23020506", "PMC6017322", "29495286"]}, {"Citation": "Simoneit U. Ph.D. Thesis. Eberhard Karls University; Tuebingen, Germany: Apr 24, 2009. Anti-Inflammatory Actions of Boswellic Acids: Identification and Critical Evaluation of Molecular Targets and Signaling Pathways."}, {"Citation": "Verhoff M., Seitz S., Paul M., Noha S.M., Jauch J., Schuster D., Werz O. Tetra- and Pentacyclic Triterpene Acids from the Ancient Anti-inflammatory Remedy Frankincense as Inhibitors of Microsomal Prostaglandin E2Synthase-1. J. Nat. Prod. 2014;77:1445\u20131451. doi: 10.1021/np500198g.", "ArticleIdList": ["10.1021/np500198g", "PMC4074212", "24844534"]}, {"Citation": "Takada Y., Ichikawa H., Badmaev V., Aggarwal B.B. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inibits invasion and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B regulated gene expression. J. Immunol. 2006;176:3127\u20133140. doi: 10.4049/jimmunol.176.5.3127.", "ArticleIdList": ["10.4049/jimmunol.176.5.3127", "16493072"]}, {"Citation": "Syrovets T., B\u00fcchele B., Krauss C., Laumonier Y., Simmet T. Acetylboswellic acids inhibt lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinase. J. Immunol. 2005;174:498\u2013506. doi: 10.4049/jimmunol.174.1.498.", "ArticleIdList": ["10.4049/jimmunol.174.1.498", "15611276"]}, {"Citation": "Ammon H.P.T. Boswellic Acids and Their Role in Chronic Inflammatory Diseases. In: Gupta S.C., Prasad S., Aggarwal B.B., editors. Anti-Inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology 928. 1st ed. Springer International Publishing; Cham, Switzerland: 2016. pp. 291\u2013326.", "ArticleIdList": ["27671822"]}, {"Citation": "Moussaieff A., Shohami E., Kashman Y., Fride E., Schmitz M.L., Renner F., Fiebich B.L., Munoz E., Ben-Neriah Y., Mechoulam R. Incensole Acetate, a novel anti-inflammatory compound isoalted from Boswellia resin, inhibits nuclear factor-\u03baB activation. Mol. Pharmacol. 2007;72:1657\u20131664. doi: 10.1124/mol.107.038810.", "ArticleIdList": ["10.1124/mol.107.038810", "17895408"]}, {"Citation": "Chevrier M.R., Ryan A.E., Lee D.Y.W., Zhongze M., Wu-Yan Z., Via C.S. Boswellia carterii Extract Inhibits TH1 Cytokines and Promotes TH2 Cytokines In Vitro. Clin. Diagn. Lab. Immunol. 2005;12:575\u2013580. doi: 10.1128/CDLI.12.5.575-580.2005.", "ArticleIdList": ["10.1128/CDLI.12.5.575-580.2005", "PMC1112084", "15879017"]}, {"Citation": "Siemoneit U., Pergola C., Jazzar B., Northoff H., Skarke C., Jauch J., Werz O. On the Interference of Boswellic Acids with 5-lipoxygenase: Mechanistic Studies In Vitro and Pharmcological Relevance. Eur. J. Pharmacol. 2009;606:246\u2013254. doi: 10.1016/j.ejphar.2009.01.044.", "ArticleIdList": ["10.1016/j.ejphar.2009.01.044", "19374837"]}, {"Citation": "Furtado N.A.J.C., Pirson L., Edelberg H., Miranda L.M., Loira-Pastoriza C., Preat V., Larondelle Y., Andr\u00e9 C.M. Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies. Molecules. 2017;22:400. doi: 10.3390/molecules22030400.", "ArticleIdList": ["10.3390/molecules22030400", "PMC6155290", "28273859"]}, {"Citation": "Gerbeth K., Meins J., Kirste S., Momm F., Schubert-Zsilavecz M., Abdel-Tawab M. Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometry. J. Pharm. Biomed. Anal. 2011;56:998\u20131005. doi: 10.1016/j.jpba.2011.07.026.", "ArticleIdList": ["10.1016/j.jpba.2011.07.026", "21855244"]}, {"Citation": "Sterk V., B\u00fcchele B., Simmet T. Effect of Food Intake on the Bioavailability of Boswellic Acids from a Herbal Preparation in Healthy Volunteers. Planta Med. 2004;70:1155\u20131160. doi: 10.1055/s-2004-835844.", "ArticleIdList": ["10.1055/s-2004-835844", "15643550"]}, {"Citation": "Kirste S., Treier M., Wehrle S.J., Becker G., Abdel-Tawab M., Gerbeth K., Hug M.J., Lubrich B., Grosu A.L., Momm F. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors. Cancer. 2011;117:3788\u20133795. doi: 10.1002/cncr.25945.", "ArticleIdList": ["10.1002/cncr.25945", "21287538"]}, {"Citation": "Buechele B., Simmet T. Analysis of 12 different pentacyclic triterpene acids from frankincense in plasma by high-performance liquid chromatography and photodiode array detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003;795:355\u2013362. doi: 10.1016/S1570-0232(03)00555-5.", "ArticleIdList": ["10.1016/S1570-0232(03)00555-5", "14522040"]}, {"Citation": "Sharma T., Jana S. Investigation of Molecular Properties that Influence the Permeability and Oral Bioavailability of Major \u03b2-Boswellic Acids. Eur. J. Drug Metab. Pharmacokinet. 2019;45:243\u2013255. doi: 10.1007/s13318-019-00599-z.", "ArticleIdList": ["10.1007/s13318-019-00599-z", "31786725"]}, {"Citation": "Yee S. In Vitro Permeability across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man: Fact or Myth. Pharm. Res. 1997;14:763\u2013766. doi: 10.1023/A:1012102522787.", "ArticleIdList": ["10.1023/A:1012102522787", "9210194"]}, {"Citation": "Kruger P., Daneshfar R., Eckert G.P., Klein J., Volmer D.A., Bahr U., M\u00fcller W.E., Karas M., Schubert-Zsilavecz M., Abdel-Tawab M. Metabolism of Boswellic Acids In Vitro and In Vivo. Drug Metab. Dispos. 2008;36:1135\u20131142. doi: 10.1124/dmd.107.018424.", "ArticleIdList": ["10.1124/dmd.107.018424", "18356270"]}, {"Citation": "Gerbeth K., H\u00fcsch J., Fricker G., Werz O., Schubert-Zsilavecz M., Abdel-Tawab M. In Vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia. 2013;84:99\u2013106. doi: 10.1016/j.fitote.2012.10.009.", "ArticleIdList": ["10.1016/j.fitote.2012.10.009", "23103296"]}, {"Citation": "Du Z., Liu Z., Ning Z., Liu Y., Song Z., Wang C., Lu A. Prospects ob boswellic acids as potential pharmaceutics. Planta Med. 2015;81:259\u2013271.", "ArticleIdList": ["25714728"]}, {"Citation": "Siemoneit U., Koeberle A., Rossi A., Dehm F., Verhoff M., Reckel S., Maier T.J., Jauch J., Northoff H., Bernhard F., et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. Br. J. Pharmacol. 2010;162:147\u2013162. doi: 10.1111/j.1476-5381.2010.01020.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.01020.x", "PMC3012413", "20840544"]}, {"Citation": "Poeckel D., Werz O. Boswellic acids: Biological actions and moelcular targets. Curr. Med. Chem. 2006;13:3359\u20133369. doi: 10.2174/092986706779010333.", "ArticleIdList": ["10.2174/092986706779010333", "17168710"]}, {"Citation": "Koeberle A., Werz O. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non-steroidal anti-inflammatory drugs (NSAIDs): A critical review. Curr. Med. Chem. 2009;16:4274\u20134296. doi: 10.2174/092986709789578178.", "ArticleIdList": ["10.2174/092986709789578178", "19754418"]}, {"Citation": "Skarke C., Kucka K., Tausch L., Werz O., Rossmanith T., Barrett J.S., Harder S., Holtmeier W., Schwarz J.A. Increased bioavailability of 11-keto-beta-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: Modeling and simulation considerations for evaluating drug exposures. J. Clin. Pharmacol. 2012;52:1592\u20131600.", "ArticleIdList": ["22167571"]}, {"Citation": "Sharma A., Gupta N.K., Dixit V.K. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid. Drug Deliv. 2010;17:587\u2013595. doi: 10.3109/10717544.2010.501461.", "ArticleIdList": ["10.3109/10717544.2010.501461", "20624027"]}, {"Citation": "H\u00fcsch J., Gerbeth K., Fricker G., Setzer C., Zirkel J., Rebmann H., Schubert-Zsilavecz M., Abdel-Tawab M. Effect of Phospholipid-Based Formulations of Boswellia serrata Extract on the Solubility, Permeability, and Absorption of the Individual Boswellic Acid Constituents Present. J. Nat. Prod. 2012;75:1675\u20131682. doi: 10.1021/np300009w.", "ArticleIdList": ["10.1021/np300009w", "23013292"]}, {"Citation": "H\u00fcsch J., Bohnet J., Fricker G., Skarke C., Artaria C., Appendino G., Schubert-Zsilavecz M., Abdel-Tawab M. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome\u00ae) of Boswellia extract. Fitoterapia. 2013;84:89\u201398. doi: 10.1016/j.fitote.2012.10.002.", "ArticleIdList": ["10.1016/j.fitote.2012.10.002", "23092618"]}, {"Citation": "Sengupta K., Kolla J.N., Krishnaraju A.V., Yalamanchili N., Rao C.V., Golakoti T., Raychaudhuri S., Raychaudhuri S.P. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: A novel Boswellia serrata extract. Mol. Cell. Biochem. 2011;354:189\u2013197. doi: 10.1007/s11010-011-0818-1.", "ArticleIdList": ["10.1007/s11010-011-0818-1", "21479939"]}, {"Citation": "Bairwa K., Jachak S.M. Development and optimisation of 3-Acetyl-11-keto-\u03b2-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and In Vivo anti-inflammatory activity in rats. J. Pharm. Pharmacol. 2015;67:1188\u20131197. doi: 10.1111/jphp.12420.", "ArticleIdList": ["10.1111/jphp.12420", "25851251"]}, {"Citation": "Mehta M., Satijy S., Nanda A., Garg M. Nanotechnolgies for boswellic acids. Am. J. Drug Discov. Dev. 2014;4:1\u201311. doi: 10.3923/ajdd.2014.1.11.", "ArticleIdList": ["10.3923/ajdd.2014.1.11"]}, {"Citation": "Meins J., Behnam D., Abdel-Tawab M. Enhanced absorption of boswellic acids by a micellar solubilized delivery form of Boswellia extract. NFS J. 2018;11:12\u201316. doi: 10.1016/j.nfs.2018.04.001.", "ArticleIdList": ["10.1016/j.nfs.2018.04.001"]}, {"Citation": "Yu G., Xiang W., Zhang T., Zeng L., Yang K., Li J. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: A systematic review and meta-analysis. BMC Complement. Med. Ther. 2020;20:1\u201316. doi: 10.1186/s12906-020-02985-6.", "ArticleIdList": ["10.1186/s12906-020-02985-6", "PMC7368679", "32680575"]}, {"Citation": "Majeed M., Majeed S., Narayanan N.K., Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother. Res. 2019;33:1457\u20131468. doi: 10.1002/ptr.6338.", "ArticleIdList": ["10.1002/ptr.6338", "PMC6681146", "30838706"]}, {"Citation": "Vishal A.A., Mishra A., Raychaudhuri S.P. A Double Blind, Randomized, Placebo Controlled Clinical Study Evaluates the Early Efficacy of Aflapin\u00ae in Subjects with Osteoarthritis of Knee. Int. J. Med. Sci. 2011;8:615\u2013622. doi: 10.7150/ijms.8.615.", "ArticleIdList": ["10.7150/ijms.8.615", "PMC3198257", "22022214"]}, {"Citation": "Sengupta K., Krishnarju A.V., Vishal A.A., Mishra A., Trimurtulu G., Sharma K.V.S., Raychaudhuri S.K., Raychaudhuri S.P. Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee: A double blind randomized, placebo controlled clinical study. Int. J. Med. Sci. 2010;7:366\u2013379. doi: 10.7150/ijms.7.366.", "ArticleIdList": ["10.7150/ijms.7.366", "PMC2974165", "21060724"]}, {"Citation": "Sengupta K., Alluri K.V., Satish A.R., Mishra S., Golakoti T., Sarma K.V., Dey D., Raychaudhuri S.P. A double-blind randomized placebo controlled clinical study of the efficacy of and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008;10:R85. doi: 10.1186/ar2461.", "ArticleIdList": ["10.1186/ar2461", "PMC2575633", "18667054"]}, {"Citation": "Kimmatkar N., Thawani V., Hingorani L., Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: A randomized double blind placebo controlled trial. Phytomedicine. 2003;10:3\u20137. doi: 10.1078/094471103321648593.", "ArticleIdList": ["10.1078/094471103321648593", "12622457"]}, {"Citation": "Sander O., Herborn G., Rau R. Is H15 (extract of Boswellia serrata \u201cincense\u201d) an efficient supplementation to established drug therapy of rhemuamtoid arthritis? Results of a double-blind pilot trial. Z. Rheumatol. 1998;57:11\u201316. doi: 10.1007/s003930050051.", "ArticleIdList": ["10.1007/s003930050051", "9566100"]}, {"Citation": "Gupta I., Parihar A., Malhotra P., Singh G.B., L\u00fcdtke R., Safayhi H., Ammon H.P. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur. J. Med. Res. 1997;2:37\u201343.", "ArticleIdList": ["9049593"]}, {"Citation": "Gupta I., Parihar A., Malhotra P., Singh G.B., L\u00fcdtke R., Safayhi H., Ammon H.P.T. Effects of Boswellia serrata gum resin in patients with chronic colitis. Planta Med. 2001;67:391\u2013395. doi: 10.1055/s-2001-15802.", "ArticleIdList": ["10.1055/s-2001-15802", "11488449"]}, {"Citation": "Gerhardt H., Seifert F., Buvari P., Vogelsang H., Repges R. Therapy of active Crohn Disease with Boswellis serrata extract H15. Z. Gastroenterol. 2001;39:11\u201317. doi: 10.1055/s-2001-10708.", "ArticleIdList": ["10.1055/s-2001-10708", "11215357"]}, {"Citation": "Madisch A., Miehlke S., Eichele O., Mrwa J., Bethke B., Kuhlisch E., B\u00e4stlein E., Wilhelms G., Morgner A., Wigginghaus B., et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int. J. Color. Dis. 2007;22:1445\u20131451. doi: 10.1007/s00384-007-0364-1.", "ArticleIdList": ["10.1007/s00384-007-0364-1", "17764013"]}, {"Citation": "Parian A., Limketkai B.N. Dietary supplement therapies for inflammatory bowel disease: Crohn\u2019s disease and ulcerative colitis. Curr. Pharm. Dis. 2016;22:180\u2013188. doi: 10.2174/1381612822666151112145033.", "ArticleIdList": ["10.2174/1381612822666151112145033", "26561079"]}, {"Citation": "Gupta I., Gupta V., Parihar A., Gupta S., L\u00fcdtke R., Safayhi H., Ammon H.P. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur. J. Med. Res. 1998;3:511\u2013514.", "ArticleIdList": ["9810030"]}, {"Citation": "Streffer J., Bitzer M., Schabet M., Dichgans J., Weller M. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15. Neurology. 2001;56:1219\u20131221. doi: 10.1212/WNL.56.9.1219.", "ArticleIdList": ["10.1212/WNL.56.9.1219", "11342692"]}, {"Citation": "Boeker D.K., Winking M. The role of boswellic acids in therapy of malignant glioma. Dt. Aerztebl. 1997;94:1197\u20131199."}, {"Citation": "Adiwidjaja J., McLachlan A.J., Boddy A.V. Curcumin as a clinically promising anti-cancer agent: Pharmacokientics and drug interactions. Expert Opin. Drug Metab. Toxicol. 2017;13:953\u2013972. doi: 10.1080/17425255.2017.1360279.", "ArticleIdList": ["10.1080/17425255.2017.1360279", "28776444"]}, {"Citation": "Fadus M.C., Lau C., Bikhchandani J., Lynch H.T. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. J. Tradit. Complement. Med. 2017;7:339\u2013346. doi: 10.1016/j.jtcme.2016.08.002.", "ArticleIdList": ["10.1016/j.jtcme.2016.08.002", "PMC5506636", "28725630"]}, {"Citation": "Kunnumakkara A.B., Bordoloi D., Padmavathi G., Monisha J., Roy N.K., Prasad S., Aggarwal B.B. Curcumin, the golden nutraceutica\u00f6: Multitargeting for multiple chronic diseases. Br. J. Pharmacol. 2017;174:1325\u20131348. doi: 10.1111/bph.13621.", "ArticleIdList": ["10.1111/bph.13621", "PMC5429333", "27638428"]}, {"Citation": "Koeberle A., Werz O. Multi-target approach for natural products in inflammation. Drug Discov. Today. 2014;19:1871\u20131882. doi: 10.1016/j.drudis.2014.08.006.", "ArticleIdList": ["10.1016/j.drudis.2014.08.006", "25172801"]}, {"Citation": "Mallo N., Lamas J., Sueiro R.A., Leiro J.M. Molecular Targets Implicated in the Antiparasitic and Anti-Inflammatory Activity of the Phytochemical Curcumin in Trichomoniasis. Molecules. 2020;25:5321. doi: 10.3390/molecules25225321.", "ArticleIdList": ["10.3390/molecules25225321", "PMC7697451", "33202696"]}, {"Citation": "Koeberle A., Northoff H., Werz O. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol. Cancer Ther. 2009;8:2348\u20132355. doi: 10.1158/1535-7163.MCT-09-0290.", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0290", "19671757"]}, {"Citation": "Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol. Sci. 2009;30:85\u201394. doi: 10.1016/j.tips.2008.11.002.", "ArticleIdList": ["10.1016/j.tips.2008.11.002", "19110321"]}, {"Citation": "Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21:2895\u20132900.", "ArticleIdList": ["11712783"]}, {"Citation": "Vareed S.K., Kakarala M., Ruffin M.T., Crowell J.A., Normolle D.P., Djuric Z., Brenner D.E. Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects. Cancer Epidemiol. Bimarkers Prev. 2008;17:1411\u20131417. doi: 10.1158/1055-9965.EPI-07-2693.", "ArticleIdList": ["10.1158/1055-9965.EPI-07-2693", "PMC4138955", "18559556"]}, {"Citation": "Hoehle S.I., Pfeiffer E., Metzler M. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Mol. Nutr. Food Res. 2007;51:932\u2013938. doi: 10.1002/mnfr.200600283.", "ArticleIdList": ["10.1002/mnfr.200600283", "17628876"]}, {"Citation": "Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S.S.R. Influence of Piperine on the Pharmacokinetics of Curcumin in Animals and Human Volunteers. Planta Med. 1998;64:353\u2013356. doi: 10.1055/s-2006-957450.", "ArticleIdList": ["10.1055/s-2006-957450", "9619120"]}, {"Citation": "Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J. Integr. Med. 2018;16:367\u2013374. doi: 10.1016/j.joim.2018.07.001.", "ArticleIdList": ["10.1016/j.joim.2018.07.001", "30006023"]}, {"Citation": "Paultre K., Cade W., Hernandez D., Reynolds J., Greif D., Best T.M. Therapeutic effects of turmeric or curcumin extract on pain and function for individuals with knee osteoarthritis: A systematic review. BMJ Open Sport Exerc. Med. 2021;7:e000935. doi: 10.1136/bmjsem-2020-000935.", "ArticleIdList": ["10.1136/bmjsem-2020-000935", "PMC7812094", "33500785"]}, {"Citation": "Wang Z., Singh A., Jones G., Winzenberg T., Ding C., Chopra A., Das S., Danda D., Laslett L., Antony B. Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr. Rheumatol. Rep. 2021;23:1\u201311. doi: 10.1007/s11926-020-00975-8.", "ArticleIdList": ["10.1007/s11926-020-00975-8", "33511486"]}, {"Citation": "Chandran B., Goel A. A randomized, pilot study to access the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 2012;26:1719\u20131725. doi: 10.1002/ptr.4639.", "ArticleIdList": ["10.1002/ptr.4639", "22407780"]}, {"Citation": "Goulart R.D.A., Barbalho S.M., Lima V.M., De Souza G.A., Matias J.N., Ara\u00fajo A.C., Rubira C.J., Buchaim R.L., Buchaim D.V., De Carvalho A.C.A., et al. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn\u2019s Disease: A Systematic Review. J. Med. Food. 2020 doi: 10.1089/jmf.2020.0129.", "ArticleIdList": ["10.1089/jmf.2020.0129", "33155879"]}, {"Citation": "Zheng T., Wang X., Chen Z., He A., Zheng Z., Liu G. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 2019;35:722\u2013729. doi: 10.1111/jgh.14911.", "ArticleIdList": ["10.1111/jgh.14911", "31696975"]}, {"Citation": "Coelho M.R., Romi M.D., Ferreira D.M.T.P., Zaltman C., Soares-Mota M. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. Nutrients. 2020;12:2296. doi: 10.3390/nu12082296.", "ArticleIdList": ["10.3390/nu12082296", "PMC7468803", "32751776"]}, {"Citation": "Chandan S., Mohan B.P., Chandan O.C., Ahmad R., Tummala H., Singh S., Dhawan P., Singh A.B. Su1871: Curcumin Use in Ulcerative Colitis\u2014Is It Ready for Prime Time? A Systematic Review and Meta-Analysis of Clinical Trials. Gastroenterology. 2019;156:53\u201358. doi: 10.1016/s0016-5085(19)38508-7.", "ArticleIdList": ["10.1016/s0016-5085(19)38508-7", "PMC6928475", "31892798"]}, {"Citation": "Sharma R.A., Ireson C.R., Verschoyle R.D., Hill K.A., Williams M.L., Leuratti M.M., Marnett L.J., Steward W.P., Gescher A. Effects of dietary curcumin on glutathione S-transferase and malodialdehyde-DNA adducts in rat liver and colon mucosa. Clin. Cancer Res. 2001;7:1452\u20131458.", "ArticleIdList": ["11350917"]}, {"Citation": "Yang Z., Liu W., Zhou X., Zhu X., Suo F., Yao S. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel disease. Medicine. 2020;99:e22916. doi: 10.1097/MD.0000000000022916.", "ArticleIdList": ["10.1097/MD.0000000000022916", "PMC7581072", "33120843"]}, {"Citation": "Tabrizi R., Vakili S., Akbari M., Mirhosseini N., Lankarani K.B., Rahimi M., Mobini M., Jafarnejad S., Vahedpoor Z., Asemi Z. The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2019;33:253\u2013262. doi: 10.1002/ptr.6226.", "ArticleIdList": ["10.1002/ptr.6226", "30402990"]}, {"Citation": "Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin. Cancer. 2004;10:6847\u20136854. doi: 10.1158/1078-0432.CCR-04-0744.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0744", "15501961"]}, {"Citation": "Li Y., Yao J., Han C., Yang J., Chaudhry M.T., Wang S., Liu H., Yin Y. Quercetin, Inflammation and Immunity. Nutrients. 2016;8:167. doi: 10.3390/nu8030167.", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}, {"Citation": "Ribeiro D., Freitas M., Tom\u00e9 S.M., Silva A.M.S., Laufer S., Lima J.L.F.C., Fernandes E. Flavonoids Inhibit COX-1 and COX-2 Enzymes and Cytokine/Chemokine Production in Human Whole Blood. Inflammation. 2014;38:858\u2013870. doi: 10.1007/s10753-014-9995-x.", "ArticleIdList": ["10.1007/s10753-014-9995-x", "25139581"]}, {"Citation": "Dabeek W.M., Marra M.V. Dietary quercetin and kaempferol: Bioavailability and potential cardiovasular-related bioactivity in humans. Nutrients. 2019;11:2288. doi: 10.3390/nu11102288.", "ArticleIdList": ["10.3390/nu11102288", "PMC6835347", "31557798"]}, {"Citation": "Pannu N., Bhatnagar A. Resveratrol: From enhanced biosynthesis and bioavailability to multitargeting chronic diseases. Biomed. Pharmacother. 2019;109:2237\u20132251. doi: 10.1016/j.biopha.2018.11.075.", "ArticleIdList": ["10.1016/j.biopha.2018.11.075", "30551481"]}, {"Citation": "Wang P., Sang S. Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors. 2018;44:16\u201325. doi: 10.1002/biof.1410.", "ArticleIdList": ["10.1002/biof.1410", "29315886"]}, {"Citation": "Walle T. Bioavailability of resveratrol. Ann. N. Y. Acad. Sci. 2011;1215:9\u201315. doi: 10.1111/j.1749-6632.2010.05842.x.", "ArticleIdList": ["10.1111/j.1749-6632.2010.05842.x", "21261636"]}, {"Citation": "Brown V.A., Patel K.R., Viskaduraki M., Crowell J.A., Perloff M., Booth T.D., Vasilinin G., Sen A., Schinas A.M., Piccirilli G., et al. Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis. Cancer Res. 2010;70:9003\u20139011. doi: 10.1158/0008-5472.CAN-10-2364.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-2364", "PMC2982884", "20935227"]}, {"Citation": "Sato S., Mukai Y. Modulation of Chronic Inflammation by Quercetin: The Beneficial Effects on Obesity. J. Inflamm. Res. 2020;13:421\u2013431. doi: 10.2147/JIR.S228361.", "ArticleIdList": ["10.2147/JIR.S228361", "PMC7425105", "32848440"]}, {"Citation": "Gualdoni G.A., Kovarik J.J., Hofer J., Dose F., Pignitter M., Doberer D., Steinberger P., Somoza V., Wolzt M., Zlabinger G.J. Resveratrol enhances TNF-\u03b1 production in human monocytes upon bacterial stimulation. Biochim. Biophys. Acta Gen. Subj. 2014;1840:95\u2013105. doi: 10.1016/j.bbagen.2013.09.009.", "ArticleIdList": ["10.1016/j.bbagen.2013.09.009", "24035785"]}, {"Citation": "Espinoza J.L., Trung L.Q., Inaoka P.T., Yamada K., An D.T., Mizuno S., Nakao S., Takami A. The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans. Oxid. Med. Cell. Longev. 2017;2017:1\u201310. doi: 10.1155/2017/6781872.", "ArticleIdList": ["10.1155/2017/6781872", "PMC5435979", "28546852"]}, {"Citation": "Shi G., Hua M., Xu Q., Ren T. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arthritis: A randomized double-blind and placebo-controlled clinical trial. Immunobiology. 2017;222:164\u2013168. doi: 10.1016/j.imbio.2016.10.008.", "ArticleIdList": ["10.1016/j.imbio.2016.10.008", "27771172"]}, {"Citation": "Samsami-Kor M., Daryani N.E., Asl P.R., Hekmatdoost A. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study. Arch. Med. Res. 2015;46:280\u2013285. doi: 10.1016/j.arcmed.2015.05.005.", "ArticleIdList": ["10.1016/j.arcmed.2015.05.005", "26002728"]}, {"Citation": "Singh A.P., Singh R., Verma S.S., Rai V., Kaschula C.H., Maiti P., Gupta S.C. Health benefits of resveratrol: Evidence from clinical studies. Med. Res. Rev. 2019;39:1851\u20131891. doi: 10.1002/med.21565.", "ArticleIdList": ["10.1002/med.21565", "30741437"]}, {"Citation": "Yoshino J., Conte C., Fontana L., Mittendorfer B., Imai S.I., Schechtman K.B., Gu C., Kunz I., Fanelli F.R., Patterson B.W., et al. Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance. Cell Metab. 2012;16:658\u2013664. doi: 10.1016/j.cmet.2012.09.015.", "ArticleIdList": ["10.1016/j.cmet.2012.09.015", "PMC3496026", "23102619"]}, {"Citation": "Ram\u00edrez-Garza S.L., Laveriano-Santos E.P., Marhuenda-Mu\u00f1oz M., Storniolo C.E., Tresserra-Rimbau A., Vallverd\u00fa-Queralt A., Lamuela-Ravent\u00f3s R.M. Health Effects of Resveratrol: Results from Human Intervention Trials. Nutrients. 2018;10:1892. doi: 10.3390/nu10121892.", "ArticleIdList": ["10.3390/nu10121892", "PMC6317057", "30513922"]}, {"Citation": "L\u00f3pez-Yerena A., Perez M., Vallverd\u00fa-Queralt A., Escribano-Ferrer E. Insights into the Binding of Dietary Phenolic Compounds to Human Serum Albumin and Food-Drug Interactions. Pharmaceutics. 2020;12:1123. doi: 10.3390/pharmaceutics12111123.", "ArticleIdList": ["10.3390/pharmaceutics12111123", "PMC7700232", "33233356"]}, {"Citation": "Batiha G.E.S., Beshbishy A.M., Ikram M., Mulla Z.S., El-Hack M.E.A., Taha A.E., Algammal A.M., Elewa Y.H.A. The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin. Foods. 2020;9:374. doi: 10.3390/foods9030374.", "ArticleIdList": ["10.3390/foods9030374", "PMC7143931", "32210182"]}, {"Citation": "Paulke A., Eckert G.P., Schubert-Zsilavecz M. Isoquercetin provides better bioavailability than quercetin: Comparison of quercetin metabolites in body tissue and brain sections after six-day administraiton of isoquercetin and quercetin. Pharmazie. 2012;67:991\u2013996.", "ArticleIdList": ["23346761"]}, {"Citation": "El-Mohsen M.A., Bayele H., Kuhnle G., Gibson G., Debnam E., Srai S.K., Rice-Evans C., Spencer J.P.E. Distribution of [H]trans-resveratrol in rat tissues following oral administration. Br. J. Nutr. 2006;96:62\u201370. doi: 10.1079/BJN20061810.", "ArticleIdList": ["10.1079/BJN20061810", "16869992"]}, {"Citation": "Wang J., Yu X., Zhang L., Wang L., Peng Z., Chen Y. The pharmacokinetics and tissue distribution of curcumin and its metabolites in mice. Biomed. Chromatogr. 2018;32:e4267. doi: 10.1002/bmc.4267.", "ArticleIdList": ["10.1002/bmc.4267", "29689635"]}, {"Citation": "Bangphumi K., Kittiviriyakul C., Towiwat P., Rojsitthisak P., Khemawoot P. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats. Eur. J. Drug Metab. Pharmacokinet. 2015;41:777\u2013785. doi: 10.1007/s13318-015-0308-z.", "ArticleIdList": ["10.1007/s13318-015-0308-z", "26563392"]}, {"Citation": "Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., Rock C.L., Pruitt M.A., Yang F., Hudspeth B., et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer\u2019s Disease. J. Pharmacol. Exp. Ther. 2008;326:196\u2013208. doi: 10.1124/jpet.108.137455.", "ArticleIdList": ["10.1124/jpet.108.137455", "PMC2527621", "18417733"]}, {"Citation": "Cas M.D., Ghidoni R. Dietary Curcumin: Correlation between Bioavailability and Health Potential. Nutrients. 2019;11:2147. doi: 10.3390/nu11092147.", "ArticleIdList": ["10.3390/nu11092147", "PMC6770259", "31500361"]}, {"Citation": "Bowman C.M., Benet L.Z. An exaination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation. Eur. J. Pharm. Sci. 2018;123:502\u2013514. doi: 10.1016/j.ejps.2018.08.008.", "ArticleIdList": ["10.1016/j.ejps.2018.08.008", "PMC6365006", "30098391"]}, {"Citation": "Poulin P., Haddad S. Albumin and uptake of drugs in cells: Additional validation excercises of a recently published equation that quantifies the albumin-facilitated uptake mechanism(s) in physiologically based pharmacokinetic and pharmacodynamic modeling research. J. Pharm. Sci. 2015;104:4448\u20134458. doi: 10.1002/jps.24676.", "ArticleIdList": ["10.1002/jps.24676", "26457988"]}, {"Citation": "Poulin P., Burczynski F.J., Haddad S. The role of extracellular binding proteins in the cellular uptake of drugs: Impact on quantitative in-vitro-in-vivo extrapolations of toxicity and efficacy in physiologically based pharmacokinetic-pharmacodynamic research. J. Phar. Sci. 2016;105:497\u2013508. doi: 10.1002/jps.24571.", "ArticleIdList": ["10.1002/jps.24571", "26173749"]}, {"Citation": "Giacomini K.M., Huang S.M., Twedie D.J., Benet L.Z., Brouwer K.I., Chu X., Dahlin A., Evers R., Fischer V., Hillgren K.M., et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010;9:215\u2013236.", "ArticleIdList": ["PMC3326076", "20190787"]}, {"Citation": "Neves A.R., Lucio M., Lima J.L., Reis S. Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions. Curr. Med. Chem. 2012;19:1663\u20131681. doi: 10.2174/092986712799945085.", "ArticleIdList": ["10.2174/092986712799945085", "22257059"]}, {"Citation": "Wanat K. Biological barriers, and the influence of protein binding on the passage of drugs across them. Mol. Biol. Rep. 2020;47:3221\u20133231. doi: 10.1007/s11033-020-05361-2.", "ArticleIdList": ["10.1007/s11033-020-05361-2", "32140957"]}, {"Citation": "Tanaka H., Mizojiri K. Drug-preotein binding and blood-brain barrier permeability. J. Pharmacol. Ther. 1999;288:912\u2013918.", "ArticleIdList": ["10027826"]}, {"Citation": "Heymans M., Sevin E., Gosselet F., Lundquist S., Culot M. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration. Eur. J. Pharm. Biopharm. 2018;127:453\u2013461. doi: 10.1016/j.ejpb.2018.03.007.", "ArticleIdList": ["10.1016/j.ejpb.2018.03.007", "29602020"]}, {"Citation": "B\u00f6hmdorfer M., Szakmary A., Schiestl R.H., Vaquero J., Riha J., Brenner S., Thalhammer T., Szekeres T., J\u00e4ger W. Involvement of UDP-Glucuronyltransferases and sulfotansferases in the excretion and tissue distribution of resveratrol in mice. Nutrients. 2017;9:1347. doi: 10.3390/nu9121347.", "ArticleIdList": ["10.3390/nu9121347", "PMC5748797", "29231856"]}, {"Citation": "Kunihiro A.G., Brickey J.A., Frye J.B., Luis P.B., Schneider C., Funk J.L. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGF\u03b2-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues. J. Nutr. Biochem. 2019;63:150\u2013156. doi: 10.1016/j.jnutbio.2018.09.021.", "ArticleIdList": ["10.1016/j.jnutbio.2018.09.021", "PMC6296872", "30393127"]}, {"Citation": "Shimoi K., Nakayama T. Glucuronidase Deconjugation in Inflammation. Methods Enzymol. 2005;400:263\u2013272. doi: 10.1016/s0076-6879(05)00015-7.", "ArticleIdList": ["10.1016/s0076-6879(05)00015-7", "16399354"]}, {"Citation": "O\u2019Leary K.A., Day A.J., Needs P.W., Sly W.S., O\u2019Brien N.M., Williamson G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett. 2001;503:103\u2013106. doi: 10.1016/S0014-5793(01)02684-9.", "ArticleIdList": ["10.1016/S0014-5793(01)02684-9", "11513863"]}, {"Citation": "Bieger J., Cermak R., Blank R., De Boer V.C.J., Hollman P.C.H., Kamphues J., Wolffram S. Tissue Distribution of Quercetin in Pigs after Long-Term Dietary Supplementation. J. Nutr. 2008;138:1417\u20131420. doi: 10.1093/jn/138.8.1417.", "ArticleIdList": ["10.1093/jn/138.8.1417", "18641184"]}, {"Citation": "Ishisaka A., Kawabata K., Miki S., Shiba Y., Minekawa S., Nishikawa T., Mukai R., Terao J., Kawai Y. Mitochondrial Dysfunction Leads to Deconjugation of Quercetin Glucuronides in Inflammatory Macrophages. PLoS ONE. 2013;8:e80843. doi: 10.1371/journal.pone.0080843.", "ArticleIdList": ["10.1371/journal.pone.0080843", "PMC3834324", "24260490"]}, {"Citation": "Galindo P., Rodr\u00edguez-G\u00f3mez I., Gonz\u00e1lez-Manzano S., Due\u00f1as M., Jim\u00e9nez R., Men\u00e9ndez C., Vargas F., Tamargo J., Santos-Buelga C., Perez-Vizcaino F., et al. Glucuronidated Quercetin Lowers Blood Pressure in Spontaneously Hypertensive Rats via Deconjugation. PLoS ONE. 2012;7:e32673. doi: 10.1371/journal.pone.0032673.", "ArticleIdList": ["10.1371/journal.pone.0032673", "PMC3299686", "22427863"]}, {"Citation": "Men\u00e9ndez C., Due\u00f1as M., Galindo P., Gonz\u00e1lez-Menzano S., Jim\u00e9nez R., Moreno L., Zarzuelo M.J., Rodriguez-G\u00f3mez I., Duarte J., Santos-Buelga C., et al. Vascular deconjugation of quercetin glucuronide: The flavonoid paradox revealed? Mol. Nutr. Food Res. 2011;55:1780\u20131790. doi: 10.1002/mnfr.201100378.", "ArticleIdList": ["10.1002/mnfr.201100378", "22144045"]}, {"Citation": "Slominski A.T., Semak I., Fischer T.W., Kim T.K., Kleszcynski K., Hardeland R., Reiter R.J. Metabolism of melatonin in the skin: Why is it important? Exp. Dermatol. 2017;26:563\u2013568. doi: 10.1111/exd.13208.", "ArticleIdList": ["10.1111/exd.13208", "PMC5348284", "27619234"]}, {"Citation": "Slominski A.T., Zmijewski M.A., Semak I., Kim T.-K., Janjetovic Z., Slominski R.M., Zmijewski J.W. Melatonin, mitochondria, and the skin. Cell. Mol. Life Sci. 2017;74:3913\u20133925. doi: 10.1007/s00018-017-2617-7.", "ArticleIdList": ["10.1007/s00018-017-2617-7", "PMC5693733", "28803347"]}, {"Citation": "Slominski A.T., Chaiprasongsuk A., Janjetovic Z., Kim T.-K., Stefan J., Slominski R.M., Hanumanthu V.S., Raman C., Qayyum S., Song Y., et al. Photoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives. Cell Biophys. 2020;78:165\u2013180. doi: 10.1007/s12013-020-00913-6.", "ArticleIdList": ["10.1007/s12013-020-00913-6", "PMC7347247", "32441029"]}, {"Citation": "Slominski A.T., Li W., Kim T.K., Semak I., Wang J., Zjawiony J.K., Tuckey R.C. Novel activities of CYP11A1 and their potential physiological significance. J. Steroid Biochem. Mol. Biol. 2015;151:25\u201337. doi: 10.1016/j.jsbmb.2014.11.010.", "ArticleIdList": ["10.1016/j.jsbmb.2014.11.010", "PMC4757911", "25448732"]}, {"Citation": "Bickel M.H., Gerny R. Drug distribution as a function of binding competetion. Experiments with the distribution dialysis technique. J. Pharm. Pharmacol. 1980;32:669\u2013674. doi: 10.1111/j.2042-7158.1980.tb13035.x.", "ArticleIdList": ["10.1111/j.2042-7158.1980.tb13035.x", "6107337"]}, {"Citation": "Clausen J., Bickel M.H. Prediction of drug distribution in distribution dialysis and in vivo from binding to tissues and blood. J. Pharm. Sci. 1993;82:345\u2013349. doi: 10.1002/jps.2600820402.", "ArticleIdList": ["10.1002/jps.2600820402", "8468675"]}, {"Citation": "Rizk M.L., Zou L., Savic R.M., E Dooley K. Importance of Drug Pharmacokinetics at the Site of Action. Clin. Transl. Sci. 2017;10:133\u2013142. doi: 10.1111/cts.12448.", "ArticleIdList": ["10.1111/cts.12448", "PMC5421734", "28160433"]}, {"Citation": "Holt K., Ye M., Nagar S., Korzekwa K. Prediction of tissue-plasma partition coefficients using microsomal partitioning: Incorporation into physiolgically based pharmacokientic models and steady-state volume of distribution predictions. Drug Met. Dispos. 2019;47:1050\u20131060. doi: 10.1124/dmd.119.087973.", "ArticleIdList": ["10.1124/dmd.119.087973", "PMC6750188", "31324699"]}, {"Citation": "Jones R.S., Chang J.H., Flores M., Brecht E. Evaluation of a competetive equilibrium dialysis approach for assessing the impact of protein binding on clearance prediction. J. Pharm. Sci. 2021;110:536\u2013542. doi: 10.1016/j.xphs.2020.09.012.", "ArticleIdList": ["10.1016/j.xphs.2020.09.012", "32941852"]}, {"Citation": "Long F., Yang H., Xu Y., Hao H., Li P. A strategy for the identification of combinatorial bioactive compounds contributing to the holistic effect of herbal medicines. Sci. Rep. 2015;5:12361. doi: 10.1038/srep12361.", "ArticleIdList": ["10.1038/srep12361", "PMC4510521", "26198093"]}, {"Citation": "Liu P., Yang H., Long F., Hao H.P., Xu X., Liu Y., Shi X.W., Zhang D.D., Zheng H.C., Wen Q.Y., et al. Bioactive Equivalence of Combinatorial Components Identified in Screening of an Herbal Medicine. Pharm. Res. 2014;31:1788\u20131800. doi: 10.1007/s11095-013-1283-1.", "ArticleIdList": ["10.1007/s11095-013-1283-1", "PMC4062815", "24549817"]}, {"Citation": "Zhuo R., Liu H., Liu N., Wang Y. Ligand Fishing: A Remarkable Strategy for Discovering Bioactive Compounds from Complex Mixture of Natural Products. Molecules. 2016;21:1516. doi: 10.3390/molecules21111516.", "ArticleIdList": ["10.3390/molecules21111516", "PMC6274472", "27845727"]}, {"Citation": "Wang Z., Liang H., Cao H., Zhang B., Li J., Wang W., Qin S., Wang Y., Xuan L., Lai L., et al. Efficient ligand siecovery from natural herbs by integrating virtual screening, affinity mass spectrometry and targeted metabolomics. Analyst. 2019;144:2881\u20132890. doi: 10.1039/C8AN02482K.", "ArticleIdList": ["10.1039/C8AN02482K", "30788466"]}, {"Citation": "Heinrich M., Lardos A., Leonti M., Weckerle C., Willcox M., Applequist W., Ladio A., Long C.L., Mukherjee P., Stafford G. Best practice in research: Consensus Statement on Ethnopharmacological Field Studies\u2014ConSEFS. J. Ethnopharmacol. 2018;211:329\u2013339. doi: 10.1016/j.jep.2017.08.015.", "ArticleIdList": ["10.1016/j.jep.2017.08.015", "28818646"]}, {"Citation": "Heinrich M., Appendino G., Efferth T., F\u00fcrst R., Izzo A.A., Kayser O., Pezzuto J.M., Viljoen A. Best practice in research: Overcoming common challenges in phytopharmacological research. J. Ethnopharmacol. 2020;246:112230. doi: 10.1016/j.jep.2019.112230.", "ArticleIdList": ["10.1016/j.jep.2019.112230", "31526860"]}, {"Citation": "Lan K., Xie G., Jia W. Towards Polypharmacokinetics: Pharmacokinetics of Multicomponent Drugs and Herbal Medicines Using a Metabolomics Approach. Evid. Based Complement. Altern. Med. 2013;2013:1\u201312. doi: 10.1155/2013/819147.", "ArticleIdList": ["10.1155/2013/819147", "PMC3612473", "23573155"]}, {"Citation": "Lan K., Jia W. An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation. Curr. Drug Met. 2010;11:105\u2013114.", "ArticleIdList": ["20302568"]}, {"Citation": "Plumb R.S., Stumpf C.L., Granger J.H., Catro-Perez J., Haselden J.N., Dear G.J. Use of liquid chromatography/time-offlight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom. 2003;17:2632\u20132638. doi: 10.1002/rcm.1250.", "ArticleIdList": ["10.1002/rcm.1250", "14648901"]}, {"Citation": "Wang X.J., Ren J.L., Zhang A.H., Sun H., Yan G.L., Han Y., Liu L. Novel applications of masspectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence. Mass Spectrom. Rev. 2019;38:380\u2013402. doi: 10.1002/mas.21589.", "ArticleIdList": ["10.1002/mas.21589", "30817039"]}, {"Citation": "Guijas C., Montenegro-Burke J.R., Warth B., E Spilker M., Siuzdak G. Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat. Biotechnol. 2018;36:316\u2013320. doi: 10.1038/nbt.4101.", "ArticleIdList": ["10.1038/nbt.4101", "PMC5937131", "29621222"]}, {"Citation": "Xie G., Wang S., Zhang H., Zhao A., Liu J., Ma Y., Lan K., Ni Y., Liu C., Liu P., et al. Poly-pharmacokinetic Study of a Multicomponent Herbal Medicine in Healthy Chinese Volunteers. Clin. Pharmacol. Ther. 2018;103:692\u2013702. doi: 10.1002/cpt.784.", "ArticleIdList": ["10.1002/cpt.784", "28675423"]}, {"Citation": "Markus J., Landry T., Stevens Z., Scott H., Llanos P., Debatis M., Armento A., Klausner M., Ayehunie S. Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays. Vitr. Cell. Dev. Biol. Anim. 2021;57:160\u2013173. doi: 10.1007/s11626-020-00526-6.", "ArticleIdList": ["10.1007/s11626-020-00526-6", "PMC7687576", "33237403"]}, {"Citation": "Srinivasan B., Kolli A.R., Esch M.B., Abaci H.E., Shuler M.L., Hickman J.J. TEER Measurement Techniques for In Vitro Barrier Model Systems. J. Lab. Autom. 2015;20:107\u2013126. doi: 10.1177/2211068214561025.", "ArticleIdList": ["10.1177/2211068214561025", "PMC4652793", "25586998"]}, {"Citation": "Costa J., Ahluwalia A. Advances and Current Challenges in Intestinal in vitro Model Engineering: A Digest. Front. Bioeng. Biotechnol. 2019;7:144. doi: 10.3389/fbioe.2019.00144.", "ArticleIdList": ["10.3389/fbioe.2019.00144", "PMC6591368", "31275931"]}, {"Citation": "Summerfield S.G., Read K., Begley D.J., Obradovic T., Hidalgo I.J., Coggon S., Lewis A.V., Porter R.A., Jeffrey P. Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction. J. Pharmacol. Exp. Ther. 2007;322:205\u2013213. doi: 10.1124/jpet.107.121525.", "ArticleIdList": ["10.1124/jpet.107.121525", "17405866"]}, {"Citation": "Nam K.H., Smith A.C.T., Lone S., Kwon S., Kim D.H. Biomimetic three-dimensional models for advanced high-throughput drug screening. J. Lab. Autom. 2015;20:201\u2013215. doi: 10.1177/2211068214557813.", "ArticleIdList": ["10.1177/2211068214557813", "PMC4459652", "25385716"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "6"}, {"Year": "2021", "Month": "4", "Day": "23"}, {"Year": "2021", "Month": "4", "Day": "29"}, {"Year": "2021", "Month": "6", "Day": "2", "Hour": "1", "Minute": "16"}, {"Year": "2021", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["34066427", "PMC8148151", "10.3390/ph14050437", "ph14050437"]}}], "PubmedBookArticle": []}